Quanterix Corporation - Common Stock (NQ:QTRX)

3.640 +0.230 (+6.74%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

August 06, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation Releases Operating Results for Second Quarter of 2021

August 05, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021

July 28, 2021

From Quanterix Corporation

Via Business Wire

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Quanterix Appoints Michael Doyle as Chief Financial Officer

June 28, 2021

From Quanterix Corporation

Via Business Wire

Medical Device Maker Quanterix Stock Shows Rising Relative Strength ↗

June 11, 2021

On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before.

Via Investor's Business Daily

Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis

June 07, 2021

From Quanterix Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 ↗

June 04, 2021

Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high...

Via Benzinga

Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report

June 02, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics

May 11, 2021

From Quanterix Corporation

Via Business Wire

64 Biggest Movers From Yesterday ↗

May 11, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 10, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Quanterix Corporation Releases Operating Results for First Quarter 2021

May 05, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021

April 28, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Appoints Laurie Olson to Board of Directors

April 28, 2021

From Quanterix Corporation

Via Business Wire

Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86 ↗

April 27, 2021

On Tuesday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into to 86, up from 80 the day before.

Via Investor's Business Daily

Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease

April 22, 2021

From Quanterix Corporation

Via Business Wire

Quanterix Announces Appointment of Interim Chief Financial Officer

April 21, 2021

From Quanterix Corporation

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.